The efficacy of current vaccines and novel Nanobody-based antivirals against highly pathogenic rabies and lyssaviruses

Edward Wright; Anna Hultberg; Valérie Rosseels; Aisling Vaughan; Michael Saunders; Mireille Koenders; Theo Verrips; Anthony R. Fooks; Steven Van Gucht; Robin A. Weiss

doi:10.1111/j.1745-7254.2005.00156.x

The efficacy of current vaccines and novel Nanobody-based antivirals against highly pathogenic rabies and lyssaviruses

Identifier:nobleid.org/w1/20260515/3FADB520

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/3FADB520.svg?ark=w1%2F20260515%2F3FADB520)](https://nobleid.org/work/w1/20260515/3FADB520)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

The efficacy of current vaccines and novel Nanobody-based antivirals against highly pathogenic rabies and lyssaviruses

Identifier:nobleid.org/w1/20260515/3FADB520

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/3FADB520.svg?ark=w1%2F20260515%2F3FADB520)](https://nobleid.org/work/w1/20260515/3FADB520)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work